Burlington Stores (NYSE:BURL) reported quarterly earnings of $2.96 per share which beat the analyst consensus estimate of $2.73 by 8.42 percent. This is a 17 percent increase over earnings of $2.53 per share from the same period last year.
Psychedelic Treatment For Alcoholism? Clearmind Medicine And SciSparc Collaboration Yields Positive Results
Clearmind Medicine Inc. (OTCPK:CMNDF) (CSE:CMND) (FSE:CWY0) a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, revealed positive safety profile results from its joint pre-clinical trial with SciSparc Ltd.
